Masanori Nakagawa Selected Research

Masanori Nakagawa Research Topics

Disease

8	Alexander Disease (Alexander's Disease) 10/2019 - 03/2002
8	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019 - 01/2009
8	Cognitive Dysfunction 01/2018 - 03/2007
8	Parkinson Disease (Parkinson's Disease) 01/2017 - 10/2006
7	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 11/2005
6	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 06/2022 - 01/2003
6	Dementia (Dementias) 01/2018 - 11/2005
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 07/2009
4	Disease Progression 10/2021 - 12/2002
4	Muscular Diseases (Myopathy) 01/2017 - 12/2010
4	Myasthenia Gravis 11/2016 - 09/2005
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022 - 01/2004
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2022 - 06/2008
3	Hypertension (High Blood Pressure) 10/2021 - 01/2005
3	CADASIL 09/2020 - 01/2008
3	Stroke (Strokes) 09/2020 - 03/2005
3	Infarction (Infarctions) 01/2018 - 02/2008
3	Parkinsonian Disorders (Parkinsonism) 01/2017 - 01/2010
3	Seizures (Absence Seizure) 01/2017 - 04/2009
3	Meningitis 01/2015 - 02/2009
3	Infections 03/2011 - 01/2006
3	Peripheral Nervous System Diseases (PNS Diseases) 03/2010 - 01/2003
2	Amyloidosis 06/2022 - 01/2009
2	Hypoxia (Hypoxemia) 03/2022 - 01/2003
2	Neuromyelitis Optica (Devic's Disease) 06/2018 - 04/2011
2	Multiple Sclerosis 01/2018 - 10/2016
2	Spinal Cord Diseases 10/2017 - 08/2007
2	Neoplasms (Cancer) 09/2017 - 08/2009
2	Multiple System Atrophy 01/2016 - 06/2014
2	Progressive Bulbar Palsy (Fazio Londe Syndrome) 07/2015 - 12/2013
2	Inflammation (Inflammations) 01/2015 - 11/2009
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 06/2014 - 01/2007
2	Dermatomyositis (Dermatopolymyositis) 05/2014 - 01/2009
2	Muscle Weakness 12/2013 - 01/2009
2	Mood Disorders (Mood Disorder) 04/2012 - 10/2009
2	Schizophrenia (Dementia Praecox) 03/2012 - 10/2009
2	Neuroleptic Malignant Syndrome 01/2012 - 01/2011
2	Polymyositis 09/2011 - 01/2009
2	Atherosclerosis 10/2010 - 11/2009
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2010 - 06/2002
2	Glioma (Gliomas) 10/2002 - 02/2002
1	Spinal Diseases (Disease, Spinal) 01/2021
1	Leukoencephalopathies 01/2020
1	Rare Diseases (Rare Disease) 10/2019
1	Inclusion Body Myositis 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 01/2018
1	Hemifacial Spasm 11/2017
1	Trigeminal Neuralgia (Tic Douloureux) 11/2017
1	Meningioma (Meningiomas) 09/2017
1	Hemolytic Anemia 01/2017
1	Nervous System Diseases (Neurological Disorders) 01/2017

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2002
8	Glial Fibrillary Acidic ProteinIBA 10/2019 - 03/2002
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2013
5	Amyloid (Amyloid Fibrils)IBA 01/2017 - 11/2005
5	SynucleinsIBA 01/2015 - 01/2012
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 01/2010
4	Mitochondrial DNA (mtDNA)IBA 09/2011 - 04/2002
3	SteroidsIBA 03/2022 - 08/2013
3	Myelin P0 Protein (Myelin Protein Zero)IBA 01/2021 - 01/2003
3	Prednisolone (Predate)FDA LinkGeneric 06/2018 - 01/2009
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 08/2013
3	alpha-SynucleinIBA 08/2010 - 10/2006
2	Prealbumin (Transthyretin)IBA 06/2022 - 01/2009
2	lomerizineIBA 09/2020 - 03/2009
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 02/2002
2	fibrin fragment D (D-dimer)IBA 01/2018 - 01/2005
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018 - 09/2011
2	GadoliniumIBA 09/2017 - 01/2011
2	AntibodiesIBA 01/2017 - 01/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 11/2013 - 04/2009
2	InterferonsIBA 01/2012 - 01/2004
2	AntigensIBA 03/2011 - 05/2002
2	DNA-Binding Proteins (DNA Binding Protein)IBA 03/2011 - 01/2009
2	Amyloid beta-PeptidesIBA 08/2010 - 12/2009
2	Pharmaceutical PreparationsIBA 03/2010 - 10/2009
2	Indicators and Reagents (Reagents)IBA 02/2010 - 02/2008
2	CytokinesIBA 11/2009 - 01/2006
2	Interferon-alpha (Interferon Alfa)IBA 08/2007 - 01/2004
1	Antihypertensive Agents (Antihypertensives)IBA 10/2021
1	Dihydrotachysterol (AT 10)IBA 09/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2020
1	Protein AggregatesIBA 01/2019
1	mecobalamin (methylcobalamin)IBA 01/2019
1	Toll-Like Receptor 4IBA 01/2018
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	proadrenomedullinIBA 01/2017
1	CollagenIBA 12/2016

Therapy/Procedure

10	Therapeutics 12/2022 - 01/2004
2	Immunotherapy 01/2017 - 11/2005
2	Activities of Daily Living (ADL) 12/2013 - 03/2007
2	Radiotherapy 04/2011 - 08/2009
1	Secondary Prevention 09/2020
1	Microvascular Decompression Surgery 11/2017